Deregulated E2F Activity Induces Hyperplasia and Senescence-Like Features in the Mouse Pituitary Gland
Open accessAbstract
The retinoblastoma gene, RB1, is one of the most frequently mutated genes in human cancer. Rb heterozygous mice develop pituitary tumors with 100% incidence, and the E2F transcription factors are required for this. To assess whether deregulated E2F activity is sufficient to induce pituitary tumors, we generated transgenic mice expressing an inducible E2F3 protein in the intermediate lobe of the pituitary gland. We found that short-term deregulation of E2F activity, similar to the earliest stages of Rb loss, is able to induce abnormal proliferation of otherwise quiescent melanotrophs. However, while long-term exposure to deregulated E2F activity results in hyperplasia of the intermediate lobe, it did not lead to tumor formation. In fact, melanotrophs become insensitive to sustained E2F stimulation and enter an irreversible senescence-like state. Thus, although deregulated E2F activity results in hyperproliferation, it is not sufficient to mimic loss of Rb, sustain proliferation of melanotrophs, and ultimately induce pituitary tumors. Similarly, we found that primary cells in tissue culture become insensitive to sustained E2F3 activation and undergo premature senescence in a pRB-, p16Ink4a-, and p19Arf-dependent manner. Thus, we conclude that deregulated E2F activity is not sufficient to fully mimic loss of Rb due to the engagement of a senescence response.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Studies in various mouse models, supported by correlative evidence from human-derived tissue samples, have underscored the tumour-suppressive role of OIS.
“Studies in various mouse models, supported by correlative evidence from human- derived tissue samples, have underscored the tumour- suppressive role of OIS 81,120-123 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [123]
The Abstract (page not supplied) reports that sustained E2F activity caused senescence-like features rather than pituitary tumors in transgenic mice, supporting a tumour-suppressive role in this mouse model. This paper does not provide the cited sentence’s correlative evidence from human-derived tissue samples; the broader statement cites several sources. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · see citing works
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862 · see citing works
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · see citing works
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 4× · see citing works
“was reported recently that specific heterochromatic structures, termed senescence-associated heterochromatic foci, form in cells undergoing “natural” replicative senescence as well as premature senescence and that the appearance of these structures correlate with epigenetic silencing of E2F target genes (32).”
BackgroundInfluentialEffects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755 · see citing works
Fero, M. L., Rivkin, M. J., Tasch, M., Porter, P. L., Carow, C. E., Firpo, E. J., Polyák, K., Tsai, L., Broudy, V. C., Perlmutter, R. M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81239-8 · Cited by 1,459 · see citing works
Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
Lee, E. Y.-H. P., Chang, C.-Y., Hu, N., Wang, Y.-C. J., Lai, C., Herrup, K., Lee, W., & Bradley, A. (1992) · Nature · doi:10.1038/359288a0 · Cited by 1,264 · see citing works
Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27
Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A., Frohman, L. A., & Koff, A. (1996) · Cell · doi:10.1016/s0092-8674(00)81238-6 · Cited by 1,243 · see citing works
Sibling rivalry in the E2F family
Trimarchi, J. M., & Lees, J. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm714 · Cited by 1,158 · see citing works
A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050 · see citing works
Requirement for a functional Rb-1 gene in murine development
Clarke, A. R., Maandag, E. R., van ROON, M. A., van der Lugt, N. M. T., van der Valk, M., Hooper, M., Berns, A. J. M., & Rielef, H. T. (1992) · Nature · doi:10.1038/359328a0 · Cited by 1,006 · see citing works
Expression of transcription factor E2F1 induces quiescent cells to enter S phase
Johnson, D. G., Schwarz, J. K., Cress, W. D., & Nevins, J. R. (1993) · Nature · doi:10.1038/365349a0 · Cited by 943 · see citing works
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
Sharpless, N. E., Bardeesy, N., Lee, K.-H., Carrasco, D., Castrillon, D. H., Aguirre, A. J., Wu, E. A., Horner, J. W., & DePinho, R. A. (2001) · Nature · doi:10.1038/35092592 · Cited by 848 · see citing works
Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.
Qin, X. Q., Livingston, D. M., Kaelin, W. G., & Adams, P. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10918 · Cited by 753 · see citing works
Müller, H., Bracken, A. P., Vernell, R., Moroni, M. C., Christians, F. C., Grassilli, E., Prosperini, E., Vigo, E., Oliner, J. D., & Helin, K. (2001) · Genes & Development · doi:10.1101/gad.864201 · Cited by 752 · see citing works
Self-citationDistinct roles for E2F proteins in cell growth control and apoptosis
DeGregori, J. V., Leone, G. W., Miron, A., Jakoi, L., & Nevins, J. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7245 · Cited by 704 · see citing works
Tumor suppression by Ink4a-Arf: progress and puzzles.
Lowe, S. W., & Sherr, C. J. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00013-8 · Cited by 699 · cited 1× · see citing works
“To further substantiate this observation, we used two independent markers of senescence, p16 and p19 (26).”
MethodTakahashi, Y., Rayman, J. B., & Dynlacht, B. D. (2000) · Genes & Development · doi:10.1101/gad.14.7.804 · Cited by 621 · see citing works
The E2F1–3 transcription factors are essential for cellular proliferation
Wu, L., Timmers, C. D., Maiti, B., Saavedra, H. I., Sang, L., Chong, G. T., Nuckolls, F., Giangrande, P. H., Wright, F. A., Field, S. J., et al. (2001) · Nature · doi:10.1038/35106593 · Cited by 620 · see citing works
Apaf-1 is a transcriptional target for E2F and p53
Moroni, M. C., Hickman, E. S., Denchi, E. L., Caprara, G., Colli, E., Cecconi, F., Müller, H., & Helin, K. (2001) · Nature Cell Biology · doi:10.1038/35078527 · Cited by 593 · see citing works
Self-citationSage, J., Mulligan, G. J., Attardi, L. D., Miller, A., Chen, S., Williams, B., Theodorou, E., & Jacks, T. (2000) · Genes & Development · doi:10.1101/gad.843200 · Cited by 582 · see citing works
The E2F family: specific functions and overlapping interests
Attwooll, C. L., Denchi, E. L., & Helin, K. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600481 · Cited by 568 · see citing works
Self-citationAcute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
Sage, J., Miller, A. L., Pérez-Mancera, P. A., Wysocki, J. M., & Jacks, T. (2003) · Nature · doi:10.1038/nature01764 · Cited by 538 · see citing works
Deregulated Expression of E2F-1 Induces S-Phase Entry and Leads to Apoptosis
Shan, B., & Lee, W. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8166 · Cited by 529 · see citing works
Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activationPreprint
Frank, S. R., Schroeder, M., Fernandez, P. C., Taubert, S., & Amati, B. B. (2001) · Genes & Development · doi:10.1101/gad.906601 · Cited by 498 · see citing works
A revised picture of the E2F transcriptional network and RB function
Nolan-Stevaux, O., & Dyson, N. J. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00388-5 · Cited by 424 · see citing works
Dimri, G. P., Itahana, K., Acosta, M., & Campisi, J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.273-285.2000 · Cited by 393 · see citing works
Tsai, K. Y., Hu, Y., Macleod, K. F., Crowley, D., Yamasaki, L., & Jacks, T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80274-9 · Cited by 372 · see citing works
E2f3 is critical for normal cellular proliferationPreprint
Humbert, P. O., Verona, R. I., Trimarchi, J. M., Rogers, C., Dandapani, S. V., & Lees, J. A. (2000) · Genes & Development · doi:10.1101/gad.14.6.690 · Cited by 334 · see citing works
CDC25A Phosphatase Is a Target of E2F and Is Required for Efficient E2F-Induced S Phase
Vigo, E., Müller, H., Prosperini, E., Hateboer, G., Cartwright, P., Moroni, M. C., & Helin, K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6379 · Cited by 326 · see citing works
Self-citationLukas, J., Petersen, B. O., Holm, K., Bartek, J., & Helin, K. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1047 · Cited by 303 · see citing works
Self-citationFranklin, D. S., Godfrey, V., O’Brien, D. A., Deng, C., & Xiong, Y. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.6147-6158.2000 · Cited by 298 · see citing works
Williams, B. O., Schmitt, E. M., Remington, L., Bronson, R. T., Albert, D. M., Weinberg, R. A., & Jacks, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06745.x · Cited by 284 · see citing works
Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/−) mice
Yamasaki, L., Bronson, R. T., Williams, B. O., Dyson, N. J., Harlow, E., & Jacks, T. (1998) · Nature Genetics · doi:10.1038/ng0498-360 · Cited by 283 · see citing works
Developmental rescue of an embryonic‐lethal mutation in the retinoblastoma gene in chimeric mice.
Robanus-Maandag, E. C., van der Valk, M., Vlaar, M., Feltkamp, C. A., O’Brien, J. M., van ROON, M. A., van der Lugt, N. M. T., Berns, A. J. M., & Riele, H. T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06746.x · Cited by 248 · see citing works
INK4a‐deficient human diploid fibroblasts are resistant to RAS‐induced senescence
Brookes, S., Rowe, J., Ruas, M., Llanos, S., Clark, P. A., Lomax, M., James, M. C., Vatcheva, R., Bates, S., Vousden, K. H., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf289 · Cited by 220 · see citing works
Ziebold, U., Reza, T., Caron, A., & Lees, J. A. (2001) · Genes & Development · doi:10.1101/gad.858801 · Cited by 200 · see citing works
Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kineticsPreprint
Aslanian, A., Iaquinta, P. J., Verona, R. I., & Lees, J. A. (2004) · Genes & Development · doi:10.1101/gad.1196704 · Cited by 170 · see citing works
Deregulated Expression of E2F-1 Induces S-Phase Entry and Leads to Apoptosis
Shan, B., & Lee, W. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8166-8173.1994 · Cited by 166 · see citing works
Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis
Conner, E. A., Lemmer, E. R., Omori, M., Wirth, P. J., Factor, V. M., & Thorgeirsson, S. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203885 · Cited by 149 · see citing works
Retinoblastoma protein meets chromatin
Brehm, A., & Kouzarides, T. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01368-7 · Cited by 148 · see citing works
Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse
Vooijs, M., van der Valk, M., Riele, H. T., & Berns, A. J. M. (1998) · Oncogene · doi:10.1038/sj.onc.1202169 · Cited by 140 · see citing works
Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development
Pierce, A. M., FISHER, S. M., Conti, C. J., & Johnson, D. G. (1998) · Oncogene · doi:10.1038/sj.onc.1201666 · Cited by 136 · see citing works
E2F-1-Induced p53-independent apoptosis in transgenic mice
Holmberg, C., Helin, K., Sehested, M., & Karlström, O. H. (1998) · Oncogene · doi:10.1038/sj.onc.1201915 · Cited by 127 · see citing works
Self-citationRegulation of two E2F-related genes in presenescent and senescent human fibroblasts.
Dimri, G. P., Hara, E., & Campisi, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33990-x · Cited by 122 · see citing works
Ziebold, U., Lee, E. Y., Bronson, R. T., & Lees, J. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.18.6542-6552.2003 · Cited by 94 · see citing works
AYu, N., & Lee, W. H. (1996) · Genes & Development · doi:10.1101/gad.10.15.1870 · Cited by 85 · see citing works
Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry
Lomazzi, M., Moroni, M. C., Jensen, M. R., Frittoli, E., & Helin, K. (2002) · Nature Genetics · doi:10.1038/ng891 · Cited by 83 · see citing works
Self-citationLiu, B., Hammer, G. D., Rubinstein, M., Mortrud, M. T., & Low, M. J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.9.3978 · Cited by 67 · see citing works
Effects of heterozygosity for the Rb-1t19neo allele in the mouse.
Harrison, D. J., Ml, H., Armstrong, J. F., & Clarke, A. R. (1995) · PubMed · Cited by 67 · see citing works
Morrison, A. J., Sardet, C., & Herrera, R. E. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.3.856-865.2002 · Cited by 63 · see citing works
Early Postnatal Development of Pituitary Intermediate Lobe Control in the Rat by Dopamine Neurons
Davis, D., LICHTENSTEIGER, W., Schlumpf, M., & Bruinink, A. (2008) · Neuroendocrinology · doi:10.1159/000123947 · Cited by 57 · see citing works
Hammer, G. D., Fairchild-Huntress, V., & Low, M. J. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-11-1689 · Cited by 56 · see citing works
Low, M. J., Liu, B., Hammer, G. D., Rubinstein, M., & Allen, R. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74558-x · Cited by 52 · see citing works
Hindelang, C., Félix, J. M., Laurent-Huck, F. M., Klein, M. J., & Stoeckel, M. E. (1990) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(90)90213-r · Cited by 36 · see citing works
Liu, B., Hammer, G. D., Rubinstein, M., et al. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.9.3978-3990.1992 · Cited by 20 · see citing works
Morphofunctional Aspects of Melanotrophic Cells Developing In Situ and In Vitroa
René, F., Hindelang, C., Vuillez, P., Plante, M., Klein, M. J., Félix, J. M., & Stoeckel, M. E. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb19677.x · Cited by 6 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [35]35. Qin, X.-Q., D. M. Livingston, W. G. Kaelin, and P. Adams. 1994. Deregu- lated E2F1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91:10918-10922.
Cited by
Sorted by citations
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · see citing works
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · see citing works
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · see citing works
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038 · see citing works
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708 · see citing works
Living on a break: cellular senescence as a DNA-damage response
d'Adda di Fagagna, F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2440 · Cited by 1,170 · see citing works
Senescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · see citing works
Cellular senescence and its effector programs
Salama, R., Sadaie, M., Hoare, M., & Narita, M. (2014) · Genes & Development · doi:10.1101/gad.235184.113 · Cited by 855 · see citing works
Exploiting senescence for the treatment of cancer
Wang, L., Lankhorst, L., & Bernards, R. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00450-9 · Cited by 867 · see citing works
Cellular senescence and tumor suppressor gene p16
Rayess, H., Wang, M. B., & Srivatsan, E. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27316 · Cited by 825 · see citing works
Senescence and cancer — role and therapeutic opportunities
Schmitt, C. A., Wang, B., & Demaria, M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00668-4 · Cited by 794 · see citing works
Erasing the methyl mark: histone demethylases at the center of cellular differentiation and diseasePreprint
Cloos, P. A., Christensen, J., Agger, K., & Helin, K. (2008) · Genes & Development · doi:10.1101/gad.1652908 · Cited by 664 · see citing works
Self-citationA novel role for high-mobility group A proteins in cellular senescence and heterochromatin formation
Narita, M., Narita, M., Krizhanovsky, V., Nuñez, S., Chicas, A., Hearn, S. A., Myers, M. P., & Lowe, S. W. (2006) · Cell · doi:10.1016/j.cell.2006.05.052 · Cited by 629 · see citing works
The dynamic nature of senescence in cancer
Lee, S., & Schmitt, C. A. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0249-2 · Cited by 588 · see citing works
Accumulation of senescent cells in Mitotic tissue of aging primates
Jeyapalan, J. C., Ferreira, M., Sedivy, J. M., & Herbig, U. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.008 · Cited by 571 · see citing works
Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis
DeGregori, J. V., & Johnson, D. G. (2006) · Current Molecular Medicine · doi:10.2174/1566524010606070739 · Cited by 499 · see citing works
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis
Sarkisian, C. J., Keister, B. A., Stairs, D. B., Boxer, R. B., Moody, S. E., & Chodosh, L. A. (2007) · Nature Cell Biology · doi:10.1038/ncb1567 · Cited by 490 · see citing works
Pathogenesis of pituitary tumors
Melmed, S. K. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.40 · Cited by 468 · see citing works
Inside and out: the activities of senescence in cancer
Pérez-Mancera, P. A., Young, A. R. J., & Narita, M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3773 · Cited by 462 · see citing works
Pro-senescence therapy for cancer treatment
Nardella, C., Clohessy, J. G., Alimonti, A., & Pandolfi, P. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3057 · Cited by 437 · see citing works
The power and the promise of oncogene-induced senescence markers
Collado, M., & Serrano, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1884 · Cited by 404 · see citing works
Many roads lead to oncogene-induced senescence
Courtois-Cox, S., Jones, S. L., & Cichowski, K. (2008) · Oncogene · doi:10.1038/sj.onc.1210950 · Cited by 397 · see citing works
Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer
Di Micco, R., Sulli, G., Dobreva, M., Liontos, M., Botrugno, O. A., Gargiulo, G., dal Zuffo, R., Matti, V., d'Ario, G., Montani, E., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2170 · Cited by 382 · see citing works
Oncogene-Induced Cell Senescence — Halting on the Road to Cancer
Mooi, W. J., & Peeper, D. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062285 · Cited by 371 · see citing works
Cellular senescence and organismal aging
Jeyapalan, J. C., & Sedivy, J. M. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.04.001 · Cited by 347 · see citing works
Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation
Ogrunc, M., Di Micco, R., Liontos, M., Bombardelli, L., Mione, M., Fumagalli, M., Gorgoulis, V. G., & d'Adda di Fagagna, F. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.16 · Cited by 328 · see citing works
What has senescence got to do with cancer?
Dimri, G. P. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.025 · Cited by 313 · see citing works
Life and death decisions by the E2F transcription factors
Iaquinta, P. J., & Lees, J. A. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.10.006 · Cited by 304 · see citing works
Cellular senescence in development, regeneration and disease
Rhinn, M., Ritschka, B., & Keyes, W. M. (2019) · Development · doi:10.1242/dev.151837 · Cited by 296 · see citing works
Oncogene-Induced Senescence: Putting the Brakes on Tumor Development
Braig, M., & Schmitt, C. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4006 · Cited by 274 · see citing works
Cellular senescence in vivo: a barrier to tumorigenesis
Prieur, A., & Peeper, D. S. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.007 · Cited by 260 · see citing works
Oncogene-induced senescence: the bright and dark side of the response
Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.07.013 · Cited by 257 · see citing works
Cellular senescence and cancer treatment
Schmitt, C. A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.005 · Cited by 254 · see citing works
Oncogenic role of miR‐17‐92 cluster in anaplastic thyroid cancer cells
Takakura, S., Mitsutake, N., Nakashima, M., Namba, H., Saenko, V., Rogounovitch, T., Nakazawa, Y., Hayashi, T., Ohtsuru, A., & Yamashita, S. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00800.x · Cited by 240 · see citing works
Senescence: a new weapon for cancer therapy
Acosta, J. C., & Gil, J. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.11.006 · Cited by 225 · see citing works
Cellular senescence in cancer: from mechanisms to detection
Ou, H., Hoffmann, R. J., González‐López, C., Doherty, G. J., Korkola, J. E., & Muñoz‐Espín, D. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12807 · Cited by 198 · see citing works
Assessing cell and organ senescence biomarkers
de Jesus, B. B., & Blasco, M. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.247866 · Cited by 187 · see citing works
Stable Cellular Senescence Is Associated with Persistent DDR Activation
Fumagalli, M., Rossiello, F., Mondello, C., & d’Adda di Fagagna, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110969 · Cited by 183 · see citing works
Tang, Y., Horikawa, I., Ajiro, M., Robles, A. I., Fujita, K., Mondal, A. M., Stauffer, J. K., Zheng, Z.-M., & Harris, C. C. (2013) · Oncogene · doi:10.1038/onc.2012.288 · Cited by 165 · see citing works
The Senescence Markers p16INK4A, p14ARF/p19ARF, and p21 in Organ Development and Homeostasis
Wagner, K., & Wagner, N. (2022) · Cells · doi:10.3390/cells11121966 · Cited by 156 · see citing works
Narita, M., & Lowe, S. W. (2005) · Nature Medicine · doi:10.1038/nm0905-920 · Cited by 150 · see citing works
Cellular senescence and chromatin structure
Funayama, R., & Ishikawa, F. (2007) · Chromosoma · doi:10.1007/s00412-007-0115-7 · Cited by 150 · see citing works
Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence
Larsson, L. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.10.005 · Cited by 147 · see citing works
Stem cells, senescence, neosis and self-renewal in cancer.
Rajaraman, R., Guernsey, D. L., Rajaraman, M. M., & Rajaraman, S. R. (2006) · Cancer Cell International · doi:10.1186/1475-2867-6-25 · Cited by 145 · see citing works
Harnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes
Al‐Ejeh, F., Kumar, R., Wiegmans, A. P., Lakhani, S. R., Brown, M. P., & Khanna, K. K. (2010) · Oncogene · doi:10.1038/onc.2010.407 · Cited by 139 · see citing works
Shamma, A., Takegami, Y., Miki, T., Kitajima, S., Noda, M., Obara, T., Okamoto, T., & Takahashi, C. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.001 · Cited by 140 · see citing works
Krizhanovsky, V., Xue, W., Zender, L., Yon, M., Hernando, E., & Lowe, S. W. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.048 · Cited by 138 · see citing works
Shahbandi, A., Rao, S. G., Anderson, A. Y., Frey, W. D., Olayiwola, J. O., Ungerleider, N., & Jackson, J. G. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0564-6 · Cited by 131 · see citing works
Olsson, A. Y., Feber, A., Edwards, S. E., Poele, R. T., Giddings, I., Merson, S., & Cooper, C. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209854 · Cited by 130 · see citing works
Oncogene-induced Cellular Senescence
Chandeck, C., & Mooi, W. J. (2010) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3181c66f4e · Cited by 115 · see citing works
E2F1 is crucial for E2F‐dependent apoptosis
Denchi, E. L., & Helin, K. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400452 · Cited by 114 · see citing works
Self-citationReshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies
D’Ambrosio, M., & Gil, J. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.05.010 · Cited by 106 · see citing works
Cellular senescence: hot or what?
Evan, G. I., & di Fagagna, F. D. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.11.009 · Cited by 109 · see citing works
Regulation of senescence and the SASP by the transcription factor C/EBPβ
Salotti, J., & Johnson, P. F. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110752 · Cited by 103 · see citing works
Hurst, C. D., Tomlinson, D. C., Williams, S. V., Platt, F. M., & Knowles, M. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210934 · Cited by 104 · see citing works
Transcriptional regulation of cellular senescence
Lanigan, F., Geraghty, J. G., & Bracken, A. P. (2011) · Oncogene · doi:10.1038/onc.2011.34 · Cited by 95 · see citing works
Cellular senescence and chromatin organisation
Narita, M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603636 · Cited by 95 · see citing works
Cellular Senescence in the Development and Treatment of Cancer
Saretzki, G. C. (2009) · Current Pharmaceutical Design · doi:10.2174/138161210789941874 · Cited by 88 · see citing works
Short-term gain, long-term pain: the senescence life cycle and cancer
Chan, A. S. L., & Narita, M. (2019) · Genes & Development · doi:10.1101/gad.320937.118 · Cited by 80 · see citing works
Connecting autophagy to senescence in pathophysiology
Young, A. R. J., & Narita, M. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.005 · Cited by 86 · see citing works
Mechanisms of Cell Cycle Arrest and Apoptosis in Glioblastoma
Gousias, K., Theocharous, T., & Simon, M. (2022) · Biomedicines · doi:10.3390/biomedicines10030564 · Cited by 86 · see citing works
Breaking news: high-speed race ends in arrest – how oncogenes induce senescence
Micco, R. D., Fumagalli, M., & di Fagagna, F. D. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.07.012 · Cited by 80 · see citing works
Purinergic P2Y14 receptor modulates stress-induced hematopoietic stem/progenitor cell senescence
Cho, J., Yusuf, R. Z., Kook, S., Attar, E. C., Lee, D., Park, B.-H., Cheng, T., Scadden, D. T., & Lee, B. C. (2014) · Journal of Clinical Investigation · doi:10.1172/jci61636 · Cited by 78 · see citing works
Cell senescence in neuropathology: A focus on neurodegeneration and tumours
Carreno, G., Guiho, R., & Martı́nez-Barberá, J. P. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12689 · Cited by 77 · see citing works
Therapeutic targeting of replicative immortality
Yaswen, P., MacKenzie, K. L., Keith, W. N., Hentosh, P., Rodier, F., Zhu, J., Firestone, G. L., Matheu, A., Carnero, A., Bilsland, A. E., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.007 · Cited by 74 · see citing works
E2F-1 regulates expression of FOXO1 and FOXO3a
Nowak, K., Killmer, K., Gessner, C., & Lutz, W. (2007) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2007.04.001 · Cited by 71 · see citing works
Corpet, A., Olbrich, T., Gwerder, M., Fink, D., & Stucki, M. (2013) · Cell Cycle · doi:10.4161/cc.26988 · Cited by 65 · see citing works
Zhao, B., Wu, B. C., Feng, N., Zhang, X., Zhang, X., Wei, Y., & Zhang, W. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01426-4 · Cited by 65 · see citing works
Epigenetic Basis of Cellular Senescence and Its Implications in Aging
Nacarelli, T., Liu, P., & Zhang, R. (2017) · Genes · doi:10.3390/genes8120343 · Cited by 63 · see citing works
Cellular Senescence in Aging Lungs and Diseases
Aghali, A., Ngassie, M. L. K., Pabelick, C. M., & Prakash, Y. S. (2022) · Cells · doi:10.3390/cells11111781 · Cited by 64 · see citing works
SRSF3: Newly discovered functions and roles in human health and diseases
More, D. A., & Kumar, A. (2020) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2020.151099 · Cited by 58 · see citing works
Regulation of self‐renewal in normal and cancer stem cells
Falzacappa, M. V. V., Ronchini, C., Reavie, L. B., & Pelicci, P. G. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08727.x · Cited by 56 · see citing works
Corpet, A., & Stucki, M. (2014) · Chromosoma · doi:10.1007/s00412-014-0469-6 · Cited by 56 · see citing works
Regulation of Senescence in Cancer and Aging
Kong, Y., Cui, H., Ramkumar, C., & Zhang, H. (2011) · Journal of Aging Research · doi:10.4061/2011/963172 · Cited by 55 · see citing works
Sample-level enrichment analysis unravels shared stress phenotypes among multiple cancer types
Gundem, G., & López-Bigas, N. (2012) · Genome Medicine · doi:10.1186/gm327 · Cited by 55 · see citing works
G Protein-Coupled Receptor Systems and Their Role in Cellular Senescence
Santos‐Otte, P., Leysen, H., van Gastel, J., Hendrickx, J. O., Martin, B., & Maudsley, S. R. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.08.005 · Cited by 54 · see citing works
Cellular senescence or stemness: hypoxia flips the coin
Otero-Albiol, D., & Carnero, A. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02035-0 · Cited by 53 · see citing works
Old cells, new tricks: chromatin structure in senescence
Parry, A. J., & Narita, M. (2016) · Mammalian Genome · doi:10.1007/s00335-016-9628-9 · Cited by 53 · see citing works
Regulation of tissue‐ and stimulus‐specific cell fate decisions by p53 in vivo
Jackson, J. G., Post, S. M., & Lozano, G. (2010) · The Journal of Pathology · doi:10.1002/path.2783 · Cited by 54 · see citing works
Komseli, E.-S., Pateras, I. S., Krejsgaard, T., Stawiski, K., Rizou, S. V., Polyzos, A., Roumelioti, F., Chiourea, M., Mourkioti, I., Paparouna, E., et al. (2018) · BMC Genomics · doi:10.1186/s12864-017-4375-1 · Cited by 49 · see citing works
Cell senescence as both a dynamic and a static phenotype
Young, A. R. J., Narita, M., & Narita, M. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_1 · Cited by 50 · see citing works
Diverse Roles of Cellular Senescence in Skeletal Muscle Inflammation, Regeneration, and Therapeutics
Saito, Y., & Chikenji, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.739510 · Cited by 48 · see citing works
The paradox of senescent-marker positive cancer cells: challenges and opportunities
O’Sullivan, E. A., Wallis, R., Mossa, F., & Bishop, C. L. (2024) · npj Aging · doi:10.1038/s41514-024-00168-y · Cited by 49 · see citing works
EGFR Induces E2F1-Mediated Corticotroph Tumorigenesis
Araki, T., Liu, X., Kameda, H., Tone, Y., Fukuoka, H., Tone, M., & Melmed, S. K. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2016-1053 · Cited by 47 · see citing works
Bunt, J., de Haas, T. G., Hasselt, N. E., Zwijnenburg, D. A., Köster, J., Versteeg, R., & Kool, M. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0546 · Cited by 46 · see citing works
Oncogene‐induced cellular senescence elicits an anti‐ <scp>W</scp> arburg effect
Li, M., Durbin, K. R., Sweet, S. M. M., Tipton, J. D., Zheng, Y., & Kelleher, N. L. (2013) · PROTEOMICS · doi:10.1002/pmic.201200298 · Cited by 43 · see citing works
Paulson, Q. X., McArthur, M. J., & Johnson, D. G. (2005) · Cell Cycle · doi:10.4161/cc.5.2.2307 · Cited by 46 · see citing works
Cellular Senescence as a Target in Cancer Control
Vergel, M., Marín, J., Estévez, P., & Carnero, A. (2010) · Journal of Aging Research · doi:10.4061/2011/725365 · Cited by 43 · see citing works
Crochemore, C., Molina, C. F., Montagne, B., Salles, A., & Ricchetti, M. (2019) · Nature Communications · doi:10.1038/s41467-019-13314-y · Cited by 40 · see citing works
Activatable senoprobes and senolytics: Novel strategies to detect and target senescent cells
Morsli, S., Doherty, G. J., & Muñoz‐Espín, D. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111618 · Cited by 41 · see citing works
Comparative Analysis of E2F Family Member Oncogenic Activity
Chen, C., & Wells, A. D. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000912 · Cited by 41 · see citing works
E2f binding-deficient Rb1 protein suppresses prostate tumor progression in vivo
Sun, H., Wang, Y., Chinnam, M., Zhang, X., Hayward, S. W., Foster, B. A., Nikitin, A. Y., Wills, M. L., & Goodrich, D. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015027108 · Cited by 41 · see citing works
Sherman, M. Y., Le, M., Stampfer, M. R., Gabai, V. L., & Yaglom, J. A. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00736.x · Cited by 37 · see citing works
Cellular senescence signaling in cancer: A novel therapeutic target to combat human malignancies
Fakhri, S., Moradi, S. Z., DeLiberto, L. K., & Bishayee, A. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114989 · Cited by 38 · see citing works
Senescence and pre-malignancy: How do tumors progress?
Saab, R. H. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.013 · Cited by 36 · see citing works
MicroRNA‐34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma
Toraih, E. A., Ibrahiem, A. T., Fawzy, M. S., Hussein, M. H., Alqahtani, S. A. M., & Shaalan, A. A. M. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3269379 · Cited by 37 · see citing works
p35 Is Required for CDK5 Activation in Cellular Senescence
Mao, D., & Hinds, P. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066118 · Cited by 37 · see citing works
O’Hara, S. P., Splinter, P. L., Trussoni, C. E., Pisarello, M. J. L., Loarca, L., Splinter, N. S., Schutte, B. F., & LaRusso, N. F. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.777409 · Cited by 36 · see citing works
Melmed, S. K., & Kleinberg, D. L. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00009-2 · Cited by 34 · see citing works
Lee, S.-J., Lee, S.-H., Yoon, M.-H., & Park, B.-J. (2013) · Neoplasia · doi:10.1593/neo.121862 · Cited by 34 · see citing works
- Authors
- Denchi, E. L., Attwooll, C., Pasini, D., & Helin, K.
- Affiliations
- European Institute of Oncology (IT)
- University of Copenhagen (DK)
- Corresponding author
- Helin, Kristian
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2005-04-01
- Volume
- 25
- Issue
- 7
- Pages
- 2660-2672
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC1061636
- OpenAlex
- W2124621255
- Cited by
- 195
- References
- 55
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 2 · 2023: 5 · 2022: 13 · 2021: 8 · 2020: 15 · 2019: 7 · 2018: 4 · 2017: 9 · 2016: 6 · 2015: 4 · 2014: 12 · 2013: 6 · 2012: 11
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- European Commission
- Associazione Italiana per la Ricerca sul Cancro
- Fondazione Italiana per la Ricerca sul Cancro
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- E2F3, retinoblastoma gene, RB1 loss, pituitary tumors, intermediate lobe, melanotrophs, cell proliferation, senescence, premature senescence, p16INK4a, p19ARF, transgenic mice
- MeSH terms
- Aging, Animals, Cells, Cultured, DNA-Binding Proteins, Hyperplasia, Mice, Transgenic, Pituitary Gland, Recombinant Proteins, Transcription Factors, Transcription, Genetic, Cell Cycle Proteins, Cell Proliferation, E2F Transcription Factors, E2F3 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
